Navigating the future of CRM in a post-Veeva-Salesforce world
This report serves as a strategic guide helping pharma companies navigate the shifting CRM landscape, evaluate evolving platform options, and build a future-ready foundation for orchestrating meaningful, personalized stakeholder experiences at scale.
To stay ahead in this competitive landscape, life sciences companies must showcase a strategic vision that unites cutting-edge AI technologies with valuable research insights, paving the way for powerful, secure, and reliable AI-driven CRM solutions.
While technology transformation is not new in life sciences, the post-Veeva-Salesforce era presents a pivotal moment. As new CRM providers emerge, enterprises must act decisively to build a future-ready CRM foundation.
The shift is driven by the need to close gaps left by traditional CRMs. Enterprises now expect a unified, dynamic stakeholder view enabled by API-driven, scalable ecosystems with enterprise-wide interoperability. The focus is on foundational process capabilities that support digital engagement, enriched by data and insights to deliver personalized experiences across all channels.
This CRM transition is no longer optional—it’s a strategic imperative. However, the path forward is complex. Success depends on identifying the right KPIs to measure adoption, usability, and business impact.
Enterprises that act decisively today will be better positioned to lead tomorrow’s CRM transformation—enabling smarter, more connected, and impactful engagement across the stakeholder journey.
